期刊文献+

紫杉醇联合5-氟脲嘧啶、亚叶酸钙治疗晚期胃癌的疗效 被引量:1

The Effect of Paclitaxel Combined with 5-fluorouracil and Calcium Folinate on Advanced Gastric Cancer
下载PDF
导出
摘要 目的探讨紫杉醇联合5-氟脲嘧啶(5-FU)、亚叶酸钙(CF)治疗晚期胃癌的疗效及不良反应。方法32例晚期胃癌患者均给予紫杉醇175 mg/m2加入5%葡萄糖注射液500 mL中3 h静脉滴注,第1天;CF 200 mg加入0.9%氯化钠注射液250 mL静脉滴注,第1-3天;5-FU 2 600 mg/m2用全自动电脑微量泵46 h泵入,第1-2天。3周重复。结果32例患者中,总有效率为43.8%,其中完全缓解(CR)4例,部分缓解(PR)10例,无变化(NC)14例,疾病进展(PD)4例。主要不良反应为:白细胞减少占75.0%,恶心、呕吐占71.9%,脱发占37.9%。结论紫杉醇联合5-FU、CF治疗晚期胃癌有较好的疗效,不良反应可以耐受。 Objective To explore the curative effect and unhoward reactions of paelitaxel combined with 5-fluorouraeil(5-FU) and calcium folinate(CF) on advanced gastric cancer. Methods Thirty-two patients with advanced gastric cancer were all treated with paclitaxel 175 mg/m^2 in 500 mL 5% glucose injection for 3 hours on day 1 ,CF 200 mg in 250 mL sodium chloriae injection on day 1-3,5-FU 2 600 mg/m^2 fully-automatic continuous micropump for 46 hours by pump on day 1-2, repeated for three-weeks. Results Among 32 patients, the overall effective rate was 43.8% ,including 4 cases with complete remission(CR)and 10 cases with partial remission(PR), 14 cases without any change(NC) ,and 4 cases with disease progress(PD). The main untoward reactions were declined white blood cell (75. 0%), Nausea and vomiting (71. 9%), depilatory (37.9%). Conclusion The paclitaxel and 5-FU,CF had a comparative good curative effect on advanced gastric cancer and untoward reactions was tolerant.
出处 《实用临床医学(江西)》 CAS 2009年第3期14-15,17,共3页 Practical Clinical Medicine
关键词 紫杉醇 胃癌 疗效 paclitaxei gastric cancer effect
  • 相关文献

参考文献2

二级参考文献19

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2王启俊,祝伟星,袁光亮.2001年北京地区癌症死亡预测[J].中华流行病学杂志,1995,16(4):195-198. 被引量:6
  • 3Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002.
  • 4Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016.
  • 5Bugat R.Irinotecan in the treatment of gastric cancer[J].Ann Oncol,2003,14(Suppl 2):37 -40.
  • 6Bouche O,Raoul JL,Bonnetain F,et al.Randomized multicenter phase Ⅱ trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2),LV5FU2 plus cisplatin,or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer:a Federation Francophone de Cancerologie Digestive Group Study-FFCD 9803[ J].J Clin Oncol,2004,22 (21):4319-4328.
  • 7Fazio N,Zampino G,Nol F,et al.Irinotecan combined with in fusional 5-fluorouracil and folinic acid (folfiri) in patients with metastatic gastric cancer resistant to cisplatin-containing chemo therapy[J].J Clin Onc,Proc Am Soc Clin Oncol,2004,22:Abstract 4146a.
  • 8Peeters M,Van Laethem JL,Baert F,et al.Phase Ⅱ study of irinotecan+ 5FU/FA for patients with previously treated ad vanced gastric cancer[J].J Clin Onc,Proc Am Soc Clin Oncol,2004,22:Abstract 4076a.
  • 9Bamias A,Papamichael D,Syrigos K,et al.Phase Ⅱ study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer[J].J Chemother,2003,15(3):275 -281.
  • 10Giuliani F,Maiello E,Molica S,et al.Irinotecan (CPT-11)and Mitomycin-C (MMC) as second-line treatment in advanced gastric cancer patients.A phase Ⅱ study of the Gruppo Oncologico dell Italia Meridionale (GOIM)[J].J Clin Onc,Proc Am Soc Clin Oncol,2004,22:Abstract 4235.

共引文献611

同被引文献5

  • 1Furue H,Taguchi T.A late phase H study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer (Abstr)[J].Ann Oncol,1998,Suppl 4 (9): 233P.
  • 2A janiJA,Fairweather J,Dum as P,et al.Phase II study of taxol in patients with advanced gastric carcinoma [J]. Cancer J Sci Am, 1998,4(4):269-276.
  • 3LokichJJ,SonnebomH,AndersonNR,et al.Combined paclitaxel,eisplatin,and etoposide for patients with previously untreated esophageal and gastreesophageal carcinomas [J]. Cancer, 1999,85 (11):2347-2351.
  • 4Gotoh M,Kawabe S,takiuchi H.S-lcombined with weekly paclitaxel in patients with advanced gastric cancer.Gan To Kagaku Ryoho.2006,33(Suppl 1):91-94.
  • 5金懋林.胃癌内科化学治疗的新进展[J].医学临床研究,2003,20(10):735-738. 被引量:68

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部